Tempus AI Stock Gains Following the ALERT Trial Result AnnouncementZacks Investment Research • 04/02/26
Tempus and Medtronic Announce ALERT Trial Results Showing AI-Driven EHR Notifications Improve Treatment for Significant Valvular Heart DiseaseBusiness Wire • 04/01/26
Tempus (TEM) Down 12.9% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 03/26/26
Tempus AI's Diagnostics and Data Arms Drive Long-Term Growth StoryZacks Investment Research • 03/23/26
Want $1 Million in Retirement? Invest $10,000 in These 2 AI Stocks and Hold for 10 Years.The Motley Fool • 03/21/26
Tempus and Blood Cancer United® Announce Collaboration to Develop One Of the Largest Pediatric Acute Myeloid Leukemia Real-World Data RegistriesBusiness Wire • 03/17/26
Tempus AI Expands Clinical Validation of AI-Powered Cancer DiagnosticsZacks Investment Research • 03/12/26
Tempus Announces Study Highlighting the Role of Advanced Genomic Profiling Features in Identifying Clinically Actionable FindingsBusiness Wire • 03/11/26
TEM's Diagnostics Arm Expanding Rapidly: What's Driving the Growth?Zacks Investment Research • 03/05/26
Tempus AI, Inc. (TEM) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 TranscriptSeeking Alpha • 03/03/26
Tempus Announces Strategic Collaboration Agreement with Merck to Accelerate AI-Driven Precision MedicineBusiness Wire • 03/03/26
Tempus to Participate in the Morgan Stanley Technology, Media & Telecom ConferenceBusiness Wire • 02/26/26